IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v609y2022i7929d10.1038_s41586-022-05215-w.html
   My bibliography  Save this article

Failure of human rhombic lip differentiation underlies medulloblastoma formation

Author

Listed:
  • Liam D. Hendrikse

    (The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children
    Developmental and Stem Cell Biology Program, The Hospital for Sick Children
    University of Toronto)

  • Parthiv Haldipur

    (Center for Integrative Brain Research, Seattle Children’s Research Institute)

  • Olivier Saulnier

    (The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children
    Developmental and Stem Cell Biology Program, The Hospital for Sick Children)

  • Jake Millman

    (Center for Integrative Brain Research, Seattle Children’s Research Institute)

  • Alexandria H. Sjoboen

    (Center for Integrative Brain Research, Seattle Children’s Research Institute)

  • Anders W. Erickson

    (The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children
    Developmental and Stem Cell Biology Program, The Hospital for Sick Children
    University of Toronto)

  • Winnie Ong

    (The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children
    Developmental and Stem Cell Biology Program, The Hospital for Sick Children
    University of Toronto)

  • Victor Gordon

    (University of Manitoba)

  • Ludivine Coudière-Morrison

    (University of Manitoba)

  • Audrey L. Mercier

    (PSL Research University, Université Paris Sud, Université Paris-Saclay, CNRS UMR 3347, INSERM U1021, Institut Curie)

  • Mohammad Shokouhian

    (University of Manitoba)

  • Raúl A. Suárez

    (The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children
    Developmental and Stem Cell Biology Program, The Hospital for Sick Children)

  • Michelle Ly

    (The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children
    Developmental and Stem Cell Biology Program, The Hospital for Sick Children
    University of Toronto)

  • Stephanie Borlase

    (University of Manitoba)

  • David S. Scott

    (The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children
    Developmental and Stem Cell Biology Program, The Hospital for Sick Children)

  • Maria C. Vladoiu

    (The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children
    Developmental and Stem Cell Biology Program, The Hospital for Sick Children
    University of Toronto)

  • Hamza Farooq

    (The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children
    Developmental and Stem Cell Biology Program, The Hospital for Sick Children
    University of Toronto)

  • Olga Sirbu

    (The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children
    Developmental and Stem Cell Biology Program, The Hospital for Sick Children
    University of Toronto)

  • Takuma Nakashima

    (Division of Brain Tumor Translational Research, National Cancer Center Research Institute)

  • Shohei Nambu

    (Division of Brain Tumor Translational Research, National Cancer Center Research Institute)

  • Yusuke Funakoshi

    (Division of Brain Tumor Translational Research, National Cancer Center Research Institute)

  • Alec Bahcheli

    (University of Toronto
    Computational Biology Program, Ontario Institute for Cancer Research)

  • J. Javier Diaz-Mejia

    (University Health Network)

  • Joseph Golser

    (Center for Integrative Brain Research, Seattle Children’s Research Institute)

  • Kathleen Bach

    (Center for Integrative Brain Research, Seattle Children’s Research Institute)

  • Tram Phuong-Bao

    (University of Manitoba)

  • Patryk Skowron

    (The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children
    Developmental and Stem Cell Biology Program, The Hospital for Sick Children
    University of Toronto)

  • Evan Y. Wang

    (The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children
    Developmental and Stem Cell Biology Program, The Hospital for Sick Children
    University of Toronto)

  • Sachin A. Kumar

    (The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children
    Developmental and Stem Cell Biology Program, The Hospital for Sick Children
    University of Toronto)

  • Polina Balin

    (The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children
    Developmental and Stem Cell Biology Program, The Hospital for Sick Children
    University of Toronto)

  • Abhirami Visvanathan

    (The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children
    Developmental and Stem Cell Biology Program, The Hospital for Sick Children)

  • John J. Y. Lee

    (The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children
    Developmental and Stem Cell Biology Program, The Hospital for Sick Children
    University of Toronto)

  • Ramy Ayoub

    (University of Toronto)

  • Xin Chen

    (The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children
    Developmental and Stem Cell Biology Program, The Hospital for Sick Children)

  • Xiaodi Chen

    (The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children
    Developmental and Stem Cell Biology Program, The Hospital for Sick Children)

  • Karen L. Mungall

    (Canada’s Michael Smith Genome Sciences Centre, BC Cancer Agency)

  • Betty Luu

    (The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children
    Developmental and Stem Cell Biology Program, The Hospital for Sick Children)

  • Pierre Bérubé

    (McGill University Genome Centre, McGill University)

  • Yu C. Wang

    (McGill University Genome Centre, McGill University)

  • Stefan M. Pfister

    (Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ)
    University Hospital Heidelberg)

  • Seung-Ki Kim

    (Seoul National University Children’s Hospital)

  • Olivier Delattre

    (SIREDO Oncology Center (Pediatric, Adolescent and Young Adults Oncology), Institut Curie
    INSERM U830, Institut Curie)

  • Franck Bourdeaut

    (SIREDO Oncology Center (Pediatric, Adolescent and Young Adults Oncology), Institut Curie
    INSERM U830, Institut Curie)

  • François Doz

    (SIREDO Oncology Center (Pediatric, Adolescent and Young Adults Oncology), Institut Curie
    Université Paris Cité)

  • Julien Masliah-Planchon

    (Unit of Somatic Genetics, Institut Curie)

  • Wieslawa A. Grajkowska

    (The Children’s Memorial Health Institute)

  • James Loukides

    (The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children)

  • Peter Dirks

    (The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children
    Developmental and Stem Cell Biology Program, The Hospital for Sick Children
    University of Toronto
    Division of Neurosurgery, The Hospital for Sick Children)

  • Michelle Fèvre-Montange

    (INSERM U1028, CNRS UMR5292, Centre de Recherche en Neurosciences, Université de Lyon
    Centre de Pathologie EST, Groupement Hospitalier EST, Université de Lyon)

  • Anne Jouvet

    (Centre de Pathologie EST, Groupement Hospitalier EST, Université de Lyon)

  • Pim J. French

    (Erasmus University Medical Center)

  • Johan M. Kros

    (Erasmus University Medical Center)

  • Karel Zitterbart

    (Masaryk University School of Medicine)

  • Swneke D. Bailey

    (McGill University
    Cancer Research Program, Research Institute of the McGill University Health Centre)

  • Charles G. Eberhart

    (John Hopkins University School of Medicine)

  • Amulya A. N. Rao

    (Division of Pediatric Hematology/Oncology, Mayo Clinic)

  • Caterina Giannini

    (Mayo Clinic)

  • James M. Olson

    (Clinical Research Division, Fred Hutchinson Cancer Research Center)

  • Miklós Garami

    (Semmelweis University)

  • Peter Hauser

    (Semmelweis University)

  • Joanna J. Phillips

    (University of California San Francisco
    University of California San Francisco)

  • Young S. Ra

    (University of Ulsan, Asan Medical Center)

  • Carmen Torres

    (Developmental Tumor Biology Laboratory, Hospital Sant Joan de Déu, Esplugues de Llobregat)

  • Jaume Mora

    (Developmental Tumor Biology Laboratory, Hospital Sant Joan de Déu, Esplugues de Llobregat)

  • Kay K. W. Li

    (The Chinese University of Hong Kong)

  • Ho-Keung Ng

    (The Chinese University of Hong Kong)

  • Wai S. Poon

    (The Chinese University of Hong Kong)

  • Ian F. Pollack

    (University of Pittsburgh School of Medicine)

  • Enrique López-Aguilar

    (Division of Pediatric Hematology/Oncology, Hospital Pediatría Centro Médico Nacional century XXI)

  • G. Yancey Gillespie

    (University of Alabama at Birmingham)

  • Timothy E. Meter

    (Pediatrics, Virginia Commonwealthy University, School of Medicine)

  • Tomoko Shofuda

    (Division of Stem Cell Research, Institute for Clinical Research, Osaka National Hospital)

  • Rajeev Vibhakar

    (University of Colorado Denver)

  • Reid C. Thompson

    (Vanderbilt Medical Center)

  • Michael K. Cooper

    (Vanderbilt Medical Center)

  • Joshua B. Rubin

    (Washington University School of Medicine in St Louis)

  • Toshihiro Kumabe

    (Kitasato University School of Medicine)

  • Shin Jung

    (Chonnam National University Research Institute of Medical Sciences, Chonnam National University Hwasun Hospital and Medical School)

  • Boleslaw Lach

    (McMaster University
    Hamilton General Hospital)

  • Achille Iolascon

    (University of Naples Federico II
    CEINGE Biotecnologie Avanzate)

  • Veronica Ferrucci

    (University of Naples Federico II
    CEINGE Biotecnologie Avanzate)

  • Pasqualino Antonellis

    (University of Naples Federico II
    CEINGE Biotecnologie Avanzate)

  • Massimo Zollo

    (University of Naples Federico II
    CEINGE Biotecnologie Avanzate)

  • Giuseppe Cinalli

    (Santobono-Pausilipon Children’s Hospital)

  • Shenandoah Robinson

    (Division of Pediatric Neurosurgery, Case Western Reserve)

  • Duncan S. Stearns

    (Case Western Reserve)

  • Erwin G. Meir

    (Emory University School of Medicine and Winship Cancer Institute)

  • Paola Porrati

    (Fondazione IRCCS Istituto Nazionale Tumori)

  • Gaetano Finocchiaro

    (Fondazione IRCCS Istituto Nazionale Tumori)

  • Maura Massimino

    (Fondazione IRCCS Istituto Nazionale Tumori)

  • Carlos G. Carlotti

    (Faculty of Medicine of Ribeirão Preto, University of São Paulo)

  • Claudia C. Faria

    (Division of Neurosurgery, Centro Hospitalar Lisboa Norte (CHULN), Hospital de Santa Maria
    Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa)

  • Martine F. Roussel

    (St Jude Children’s Research Hospital)

  • Frederick Boop

    (St Jude Children’s Research Hospital)

  • Jennifer A. Chan

    (University of Calgary)

  • Kimberly A. Aldinger

    (Center for Integrative Brain Research, Seattle Children’s Research Institute
    Brotman Baty Institute for Precision Medicine)

  • Ferechte Razavi

    (Assistance Publique Hôpitaux de Paris, Hôpital Necker-Enfants Malades)

  • Evelina Silvestri

    (Surgical Pathology Unit, San Camillo Forlanini Hospital)

  • Roger E. McLendon

    (Duke University
    Duke University)

  • Eric M. Thompson

    (Duke University)

  • Marc Ansari

    (University of Geneva
    University Geneva Hospitals)

  • Maria L. Garre

    (U.O. Neurochirurgia, Istituto Giannina Gaslini)

  • Fernando Chico

    (Department of Neurosurgery, Hospital Infantil de Mexico Federico Gomez)

  • Pilar Eguía

    (Department of Neurosurgery, Hospital Infantil de Mexico Federico Gomez)

  • Mario Pérezpeña

    (Instituto Nacional De Pediatría de México)

  • A. Sorana Morrissy

    (University of Calgary
    University of Calgary
    Alberta Children’s Hospital Research Institute)

  • Florence M. G. Cavalli

    (INSERM U900, Institut Curie
    PSL Research University, Institut Curie
    CBIO-Centre for Computational Biology, PSL Research University, MINES ParisTech)

  • Xiaochong Wu

    (The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children
    Developmental and Stem Cell Biology Program, The Hospital for Sick Children)

  • Craig Daniels

    (The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children
    Developmental and Stem Cell Biology Program, The Hospital for Sick Children)

  • Jeremy N. Rich

    (UPMC Hillman Cancer Center)

  • Steven J. M. Jones

    (Canada’s Michael Smith Genome Sciences Centre, BC Cancer Agency
    University of British Columbia
    Simon Fraser University)

  • Richard A. Moore

    (Canada’s Michael Smith Genome Sciences Centre, BC Cancer Agency)

  • Marco A. Marra

    (Canada’s Michael Smith Genome Sciences Centre, BC Cancer Agency
    University of British Columbia)

  • Xi Huang

    (The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children
    Developmental and Stem Cell Biology Program, The Hospital for Sick Children
    University of Toronto)

  • Jüri Reimand

    (University of Toronto
    University of Toronto
    Computational Biology Program, Ontario Institute for Cancer Research)

  • Poul H. Sorensen

    (University of British Columbia
    BC Cancer Agency)

  • Robert J. Wechsler-Reya

    (Tumor Initiation and Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute)

  • William A. Weiss

    (University of California San Francisco
    University of California San Francisco
    University of California San Francisco)

  • Trevor J. Pugh

    (University of Toronto
    Computational Biology Program, Ontario Institute for Cancer Research
    University Health Network)

  • Livia Garzia

    (Cancer Research Program, McGill University Health Centre Research Institute)

  • Claudia L. Kleinman

    (McGill University
    Lady Davis Research Institute, Jewish General Hospital)

  • Lincoln D. Stein

    (University of Toronto
    Adaptive Oncology, Ontario Institute for Cancer Research)

  • Nada Jabado

    (McGill University
    The Research Institute of the McGill University Health Center)

  • David Malkin

    (University of Toronto
    The Hospital for Sick Children)

  • Olivier Ayrault

    (PSL Research University, Université Paris Sud, Université Paris-Saclay, CNRS UMR 3347, INSERM U1021, Institut Curie)

  • Jeffrey A. Golden

    (Cedars-Sinai Medical Center)

  • David W. Ellison

    (St Jude Children’s Research Hospital)

  • Brad Doble

    (University of Manitoba)

  • Vijay Ramaswamy

    (The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children
    Developmental and Stem Cell Biology Program, The Hospital for Sick Children
    University of Toronto
    The Hospital for Sick Children)

  • Tamra E. Werbowetski-Ogilvie

    (University of Manitoba
    CancerCare Manitoba Research Institute)

  • Hiromichi Suzuki

    (Division of Brain Tumor Translational Research, National Cancer Center Research Institute)

  • Kathleen J. Millen

    (Center for Integrative Brain Research, Seattle Children’s Research Institute)

  • Michael D. Taylor

    (The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children
    Developmental and Stem Cell Biology Program, The Hospital for Sick Children
    University of Toronto
    University of Toronto)

Abstract

Medulloblastoma (MB) comprises a group of heterogeneous paediatric embryonal neoplasms of the hindbrain with strong links to early development of the hindbrain1–4. Mutations that activate Sonic hedgehog signalling lead to Sonic hedgehog MB in the upper rhombic lip (RL) granule cell lineage5–8. By contrast, mutations that activate WNT signalling lead to WNT MB in the lower RL9,10. However, little is known about the more commonly occurring group 4 (G4) MB, which is thought to arise in the unipolar brush cell lineage3,4. Here we demonstrate that somatic mutations that cause G4 MB converge on the core binding factor alpha (CBFA) complex and mutually exclusive alterations that affect CBFA2T2, CBFA2T3, PRDM6, UTX and OTX2. CBFA2T2 is expressed early in the progenitor cells of the cerebellar RL subventricular zone in Homo sapiens, and G4 MB transcriptionally resembles these progenitors but are stalled in developmental time. Knockdown of OTX2 in model systems relieves this differentiation blockade, which allows MB cells to spontaneously proceed along normal developmental differentiation trajectories. The specific nature of the split human RL, which is destined to generate most of the neurons in the human brain, and its high level of susceptible EOMES+KI67+ unipolar brush cell progenitor cells probably predisposes our species to the development of G4 MB.

Suggested Citation

  • Liam D. Hendrikse & Parthiv Haldipur & Olivier Saulnier & Jake Millman & Alexandria H. Sjoboen & Anders W. Erickson & Winnie Ong & Victor Gordon & Ludivine Coudière-Morrison & Audrey L. Mercier & Moha, 2022. "Failure of human rhombic lip differentiation underlies medulloblastoma formation," Nature, Nature, vol. 609(7929), pages 1021-1028, September.
  • Handle: RePEc:nat:nature:v:609:y:2022:i:7929:d:10.1038_s41586-022-05215-w
    DOI: 10.1038/s41586-022-05215-w
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41586-022-05215-w
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1038/s41586-022-05215-w?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Oliver J. Mainwaring & Holger Weishaupt & Miao Zhao & Gabriela Rosén & Anna Borgenvik & Laura Breinschmid & Annemieke D. Verbaan & Stacey Richardson & Dean Thompson & Steven C. Clifford & Rebecca M. H, 2023. "ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors," Nature Communications, Nature, vol. 14(1), pages 1-19, December.
    2. Emma Martell & Helgi Kuzmychova & Esha Kaul & Harshal Senthil & Subir Roy Chowdhury & Ludivine Coudière Morrison & Agnes Fresnoza & Jamie Zagozewski & Chitra Venugopal & Chris M. Anderson & Sheila K. , 2023. "Metabolism-based targeting of MYC via MPC-SOD2 axis-mediated oxidation promotes cellular differentiation in group 3 medulloblastoma," Nature Communications, Nature, vol. 14(1), pages 1-26, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:609:y:2022:i:7929:d:10.1038_s41586-022-05215-w. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.